Surgery Partners director Dean Lloyd files Form 3

Surgery Partners, Inc. director Dean Lloyd H filed an initial Form 3 reporting his beneficial ownership in the company.

Rhea-AI Filing Summary

Surgery Partners, Inc. director Dean Lloyd H filed an initial Form 3 reporting his beneficial ownership in the company. The filing shows that, as of February 26, 2026, he reported 0 shares of Surgery Partners common stock held directly.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Dean Lloyd H

Role Director

Type	Security	Shares	Price	Value
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 0 shares (Direct)

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Dean Lloyd H's Form 3 filing for SGRY report?

The Form 3 filing shows that director Dean Lloyd H reported his initial ownership position in Surgery Partners, Inc.. As of February 26, 2026, he reported 0 shares of the company’s common stock held directly.

Does Surgery Partners (SGRY) director Dean Lloyd H own any common stock?

According to the Form 3, director Dean Lloyd H reported 0 shares of Surgery Partners common stock owned directly as of February 26, 2026. This indicates no reported beneficial ownership at the time of the filing.

What is the purpose of the Form 3 filed for Surgery Partners (SGRY)?

The Form 3 serves as an initial statement of beneficial ownership for insiders of Surgery Partners, Inc.. In this case, director Dean Lloyd H used it to disclose that he held 0 shares of common stock as of February 26, 2026.

Which security is covered in Dean Lloyd H’s Form 3 for SGRY?

The Form 3 covers Common Stock of Surgery Partners, Inc.. Director Dean Lloyd H reported a total of 0 shares of this security owned directly as of February 26, 2026, indicating no reported beneficial holdings.

Is the Form 3 filing for Surgery Partners (SGRY) a buy or sell transaction?

The Form 3 for Surgery Partners, Inc. is an initial ownership report, not a buy or sell transaction. Director Dean Lloyd H reported 0 shares of common stock held directly as of February 26, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/09/2026 - 07:09 PM EDT Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Dean Lloyd H

(Last) (First) (Middle)

340 SEVEN SPRINGS WAY, SUITE 600

(Street)

BRENTWOOD TN 37027

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
02/26/2026

3. Issuer Name and Ticker or Trading Symbol
Surgery Partners, Inc. [ SGRY ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	0	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

Exhibit List: Exhibit 24-Power of Attorney

	/s/ Jennifer Baldock, Attorney-in-Fact	03/09/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.